Replies to post #46029 on Kraig Biocraft Laboratories Inc (KBLB)

[sojomy]

Bottomline you are misinterpreting what Red said. The company gets more valuable with each development. That is a true statement in and of itself. You are gauging value by share price. Value increases can also be judged by market capitalization and by developments themselves. Some people get tired of the truth, but that takes nothing away from the truth. It is a better time to buy than we have seen for quite a while. You have to look at CEO history to determine which ones to apply the 6 month rule, but generally it is a rule of thumb. Few actually under promise. (I don't mean promise literally, but as used in the phrase under promise over deliver) So value may or may not be reflected in the price of a stock....and Warren Buffet will tell you the same thing. It is basic stuff and certainly should not be synonymously mischaracterized/linked with share price.

There you go, assuming you know what I think. You know what they say about when you assume... it makes (just) you look like an a$$. I have not said a word about the share price at all, but your whole diatribe above seems to assume that it's what I was talking about. I have said nothing about gauging value by share price.

Let's base it on developments. Besides a couple of fluff PRs about getting new lab space, which they will not give any details about (including size, location, what specifically they're doing inside of it, etc), what accomplishments have you heard about this year? I don't remember hearing anything new since last october or november-ish. Yes, the PNAS publication was a good thing, but it was a review of 18-month-old accomplishments. What substantive developments has the company made in the last 6-8 months? When does it start becoming just a repetetive, "We're making great strides, we're ramping up production, we should be able to generate revenues soon!" How long do you give a company before you realize that "soon" doesn't really mean near-term?